Karim R. Yanin

Karim R. Yanin

Auto-generated profile, based on publicly available information

Karim R. Yanin

Botkin Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in Russian Open Medical Journal
Verified
Journal Article
Closed access
OGOlga I. Gumeniuk
Olga I. Gumeniuk
KYKarim R. Yanin
Karim R. Yanin
AFAnna V. Fisun
Anna V. Fisun
YCYuriy V. Chernenkov
Yuriy V. Chernenkov
ASAleksander A. Stepanov
Aleksander A. Stepanov
We describe a clinical case of Alpers-Huttenlocher syndrome in a child with polyneuropathy, myopathy and epileptic seizures, the development of toxic hepatitis with a fatal outcome after the use of valproic acid as an antiepileptic drug. The need for early differential diagnosis of Alpers syndrome and molecular genetic testing in cases of damage to the nervous system with various symptoms in order to select optimal therapy is shown.

1 January 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
KYK.R. Yanin
K.R. Yanin
OGO.I. Gumeniuk
O.I. Gumeniuk
AKA.G. Korotkov
A.G. Korotkov
TYT.A. Yanina
T.A. Yanina
Yanin KR, Gumeniuk OI, Korotkov AG, Yanina TA. Molecular genetic causes of epilepsy in children. S.S. Korsakov Journal of Neurology and Psychiatry.

3 November 2026 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
NSN.A. Skripkina
N.A. Skripkina
ACA.D. Chebotareva
A.D. Chebotareva
KYK.R. Yanin
K.R. Yanin
OLOleg Levin
Oleg Levin
ISI.G. Smolentseva
I.G. Smolentseva
Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group of hereditary disorders characterized by iron accumulation in the brain, predominantly affecting the basal ganglia. These conditions present with multisystem clinical manifestations, most notably motor, cognitive, and behavioral disorders. To date, ten variants of NBIA have been identified, with BPAN, PKAN, and PLAN being the most common. This report presents five confirmed cases of type 4 NBIA, termed mitochondrial membrane protein-associated neurodegeneration (MPAN), detailing clinical and neuroimaging findings and its molecular genetic characteristics; MPAN is associated with mutations in the C19orf12 gene encoding a mitochondrial membrane protein.